8-KThe WireRoutine
Company Update
Filed May 15, 2026 · 1mo ago · Accession 0001651308-26-000012
Plain English
BeOne Medicines Ltd. announced that its drug, BEQALZI™ (sonrotoclax), received accelerated approval from the U.S. Food and Drug Administration. This approval is for adult patients with relapsed or refractory mantle cell lymphoma.
Filing details
- Company
- BeOne Medicines Ltd.
- Ticker
- ONC
- CIK
- 1651308
- Form type
- 8-K
- Filing date
- May 15, 2026
- Report date
- May 13, 2026
- Document
- bgne-20260513.htm
- Size
- 200 KB